BELL — Belluscura Share Price
Last trade - 00:00- £2.61m
- £1.95m
- $0.83m
- 15
- 45
- 10
- 11
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.19 | ||
| Price to Tang. Book | 0.45 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.92 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -94.21% | ||
| Return on Equity | -85.01% | ||
| Operating Margin | -971% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.13 | n/a | 0.42 | 1.4 | 0.83 | 4.41 | 12.73 | 27.44% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Belluscura PLC is a United Kingdom-based medical device developer company. The Company is focused on developing lightweight and portable oxygen enrichment technology. The Company's product X-PLOR, is a modular portable oxygen concentrator. The X-PLOR is lightweight, specifically designed to replace metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLOR can deliver up to 95% pure oxygen to patients 24 hours a day, seven days a week. The Company is focused on developing medical devices who suffer from chronic lung diseases, such as the Chronic Obstructive Pulmonary Disease (COPD), respiratory distress caused by COVID-19, and many other respiratory disorders. It is also focused on developing, licensing and manufacturing portable oxygen concentrators for use in treating lung diseases with its oxygen platform technologies, to include recreational and industrial oxygen concentrators, wound care devices, drug delivery devices and more.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- December 10th, 2015
- Public Since
- May 28th, 2021
- No. of Employees
- 35
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 401,309,607
- Address
- 15 Fetter Lane, LONDON, EC4A 1BW
- Web
- https://www.belluscura.com/
- Phone
- Contact
- Matthew Taylor
- Auditors
- Gerald Edelman
Latest News for BELL
Upcoming Events for BELL
Full Year 2024 Belluscura PLC Earnings Release
Belluscura PLC Annual Shareholders Meeting
Half Year 2025 Belluscura PLC Earnings Release
Similar to BELL
Abingdon Health
London Stock Exchange
Advanced Medical Solutions
London Stock Exchange
Angle
London Stock Exchange
Aoti
London Stock Exchange
Aptamer
London Stock Exchange
FAQ
As of Today at 19:34 UTC, shares in Belluscura are trading at 0.65p. This share price information is delayed by 15 minutes.
Shares in Belluscura last closed at 0.65p and the price had moved by -91.33% over the past 365 days. In terms of relative price strength the Belluscura share price has underperformed the FTSE All Share Index by -91.67% over the past year.
The overall consensus recommendation for Belluscura is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreBelluscura does not currently pay a dividend.
Belluscura does not currently pay a dividend.
Belluscura does not currently pay a dividend.
To buy shares in Belluscura you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 0.65p, shares in Belluscura had a market capitalisation of £2.61m.
Here are the trading details for Belluscura:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: BELL
Based on an overall assessment of its quality, value and momentum Belluscura is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Belluscura is 6.87p. That is 957.29% above the last closing price of 0.65p.
Analysts covering Belluscura currently have a consensus Earnings Per Share (EPS) forecast of -$0.05 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Belluscura. Over the past six months, its share price has underperformed the FTSE All Share Index by -94.26%.
As of the last closing price of 0.65p, shares in Belluscura were trading -92.47% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Belluscura PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 0.65p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Belluscura's directors